92540 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#2NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE
#3CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#4A NOVEL PROCESS FOR THE PREPARATION OF TAPENTADOL
#5Compositions for the treatment of pulmonary fibrosis
#6Co-crystals of lithium benzoate and uses thereof
#7D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease
#8CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#9CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#10Compositions for the treatment of pulmonary fibrosis
#11Co-crystals of lithium benzoate and uses thereof
#12Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#13Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#14Macrocyclic ghrelin receptor modulators and methods of using the same
#15Compositions for the treatment of fibrosis and fibrosis-related conditions
#16Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#17Ddopamine receptor agonists to treat dyskinesia in Parkinson's disease
#18STABLE POLYMORPH FORM B OF TAPENTADOL HYDROCHLORIDE
#19Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#20PHARMACEUTICAL SALTS
#21Macrocyclic ghrelin receptor modulators and methods of using the same
#22Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#23Solid state forms of tapentadol salts
#24Desfesoterodine salts
#25Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
#26Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#27D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
#28Ddopamine receptor agonists to treat dyskinesia in parkinson's disease
#29Substituted n-pentanamide compounds, preparation method and the use thereof
#30Crystalline Forms of (-)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#31Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor
#32STEREOSELECTIVE SYNTHESIS OF TAPENTADOL AND ITS SALTS
#33Solid state forms of tapentadol salts
#34Process for the preparation of 2-hydroxy-4-phenyl-3,4-dihydro-2H-chromen-6-yl-methanol and (R)-feso-deacyl
#35Methods of reducing virulence in bacteria
#36Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
#37Intermediate compounds and processes for the preparation of tapentadol and related compounds
#38Desfesoterodine in the form of a tartaric acid salt
#39Pharmaceutical salts
#40PROCESS FOR THE PREPARATION OF (R)-2-(3-DIISOPROPYLAMINO)-1-PHENYLPROPYL)-4METHYLPHENOL AND SALTS THEREOF
#41Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
#42METHOD OF OBTAINING 3,3-DIPHENYLPROPYLAMINES
#43Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
#44PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF
#45Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
#46Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
#47DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF
#48PROCESS FOR PREPARING 3,3-DIARYLPROPYLAMINES
#49Solid state forms of tapentadol salts
#50Acid salt of tolterodine having effective stability for transdermal drug delivery system
#51Shortened synthesis using paraformaldehyde or trioxane
#52Method of obtaining 3,3-diphenylpropylamines
#53SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#54AMORPHOUS FORM OF TAPENTADOL HYDROCHLORIDE
#55Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-N-alkyl-3-phenylpropylamines
#56Process for the Preparation of Fesoterodine
#57CRYSTALLINE TOLTERODINE TARTARATE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#58Accelerated synthesis of substituted hydroxymethyl phenols
#59Crystalline forms of (−)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#60Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol
#61Preparation of 3-[(1,2)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol
#62Synthesis of substituted hydroxymethyl phenols
#63Process for the production of benzopyran-2-ol derivatives
#64PHARMACEUTICAL SALTS
#65Amine Derivatives
#66Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
#67Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#68Crystalline modifications of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
#69Macrocyclic ghrelin receptor modulators and methods of using the same
#70Process for preparing 3,3-diarylpropylamines
#71PROCESS FOR PREPARING TOLTERODINE
#72Process for the preparation of tolterodine
#73Process for Preparation of 3-(2-Hydroxy-5Methylphenyl)-N, N-Disopropyl-3-Phenylpropylamine
#74Amine derivatives for the treatment of asthma and COPD
#75Crystalline forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#76Tolterodine, compositions and uses thereof, and preparation of the same
#77Enantioselective synthesis of enantiomerically enriched compounds
#78Process for the preparation of substituted 3-aryl-butylamine compounds
#79Process for preparing tolterodine tartrate
#80Substantially pure tolterodine tartrate and process for preparing thereof
#81Process for the preparation of tolterodine
#82Process for the manufacture of disubstituted amines
#83Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
#84Process for preparing tolterodine
#85Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamine
#86Pharmaceutical salts
#87Phenol derivative
#88Polymorphs of tolterodine tartrate
#89Aminoalcohol derivatives and their use as beta 3 adrenergic agonists